Pérez García M D, Rodríguez Alonso A, Núñez López A, Ojea Calvo A, Alonso Rodrigo A, Rodríguez Iglesias B, Barros Rodríguez M, Benavente Delgado J, González-Carreró Fojón J, Nogueira March J L
Servicio de Urología, Hospital Xeral-Cíes, Vigo, Pontevedra.
Actas Urol Esp. 2000 Feb;24(2):197-201. doi: 10.1016/s0210-4806(00)72430-2.
Abdomino-pelvic actinomycosis is a condition caused by Actinomyces israelii, a Gram-positive opportunistic bacteria that triggers and develops the infection only in previously injured tissues, and then slowly progresses and spreads until it extrinsically affects the urinary tract. Use of an intrauterine device is a known risk factor to suffer from this disease. Relative risk in IUD users is two- to four-fold higher compared to IUD non-users. Risk increased with prolonged IUD use. Treatment is by removal of the causative agent, surgical resection of necrotic tissues and administration of intravenous Penicillin G, 4 million units every 4 hours for 30 days, followed by Amoxicillin 500 mg every 8 hours for 12 months. This paper contributes two cases of abdomino-pelvic actinomycosis with urinary tract involvement in IUD users. Standard treatment was employed with good evolution.
腹盆腔放线菌病是由以色列放线菌引起的一种疾病,以色列放线菌是一种革兰氏阳性机会致病菌,仅在先前受损的组织中引发和发展感染,然后缓慢进展并扩散,直至对外源性地影响泌尿系统。使用宫内节育器是患此病的一个已知风险因素。宫内节育器使用者的相对风险比未使用者高两到四倍。风险随着宫内节育器使用时间的延长而增加。治疗方法是去除病原体、手术切除坏死组织,并静脉注射青霉素G,每4小时400万单位,持续30天,随后每8小时口服阿莫西林500毫克,持续12个月。本文报道了两例宫内节育器使用者并发腹盆腔放线菌病累及泌尿系统的病例。采用了标准治疗方法,病情进展良好。